Lysostaphin

Handbook of Proteolytic Enzymes, Second Edition: Volume 1: Aspartic and Metallo Peptidases

Volumn 1, Issue , 2004, Pages 1004-1005

  Park, Pyong Woo ^a   Mecham, Robert P ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77649275106     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-079611-3.50314-1     Document Type: Chapter

References (22)

1. T. Baba and O. Schneewind (1996) Target cell specificity of a bacteriocin molecule – a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus. EMBO J. 15 4789-4797.
2. E.C. Chan (1996) Expression and purification of recombinant lysostaphin in Escherichia coli. Biotechnol. Lett. 18 833-838.
3. J.J. Dajcs, E.B. Hume, J.M. Moreau, A.R. Caballero, B.M. Cannon and R.J. O'Callaghan (2000) Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Invest. Ophthalmol. Vis. Sci. 41 1432-1437.
4. B.L.M. de Jonge, T. Sidow, Y.S. Chang, H. Labischinski, B. Berger-Bachi, D.A. Gage and A. Tomasz (1993) Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus. J. Bacteriol. 175 2779-2782.
5. H.P. DeHart, H.E. Heath, L.S. Heath, P.A. LeBlanc and G.L. Sloan (1995) The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus. Appl. Environ. Microbiol. 61 1475-1479.
6. H.E. Heath, L.S. Heath, J.D. Nitterauer, K.E. Rose and G.L. Sloan (1989) Plasmid-encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphylolyticus. Biochem. Biophys. Res. Commun. 160 1106-1109.
7. P. Heinrich, R. Rosenstein, M. Böhmer, P. Sonner and F. Götz (1987) The molecular organization of the lysostaphin gene and its sequences repeated in tandem. Mol. Gen. Genet. 209 563-569.
8. M.M. Huber and T.W. Huber (1989) Susceptibility of methicillin-resistant Staphylococcus aureus to lysostaphin. J. Clin. Microbiol. 27 1122-1124.
9. O. Iversen and A. Grov (1973) Studies on lysostaphin. Separation and characterization of three enzymes. Eur. J. Biochem. 38 293-300.
10. A. Janoff and J. Blondin (1973) The effect of human granulocyte elastase on bacterial suspensions. Lab. Invest. 29 454-457.
11. E. Kessler, M. Safrin, J.C. Olson and D.E. Ohman (1993) Secreted lasA of Pseudomonas aeruginosa is a staphylolytic protease. J. Biol. Chem. 268 7503-7508.
12. H. Maidhof, B. Reinicke, P. Blümel, B. Berger-Bächi and H. Labischinski (1991) femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. J. Bacteriol. 173 3507-3513.
13. M.L. Malatesta, H.E. Heath, P.A. LeBlanc and G.L. Sloan (1992) EGTA inhibition of DNase activity in commercial lysostaphin preparations. Biotechniques 12 71-72.
14. P.W. Park, R.M. Senior, G.L. Griffin, T.J. Broekelmann, M.S. Mudd and R.P. Mecham (1995) Binding and degradation of elastin by the staphylolytic enzyme lysostaphin. Int. J. Biochem. Cell Biol. 27 139-146.
15. R.L. Patron, M.W. Climo, B.P. Goldstein and G.L. Archer (1999) Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 43 1754-1755.
16. P.A. Recsei, A.D. Gruss and R.P. Novick (1987) Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans. Proc. Natl. Acad. Sci. USA 84 1127-1131.
17. E.P. Reeves, H. Lu, H.L. Jacobs, C.G.M. Messina, S. Bolsover, G. Gabella, E.O. Potma, A. Warley, J. Roes and A.W. Segal (2002) Killing activity of neutrophils is mediated through activation of proteases by K+flux. Nature 416 291-297.
18. C.A. Schindler and V.T. Schuhardt (1964) Lysostaphin: A new bacteriolytic agent for the Staphylococcus. Proc. Natl. Acad. Sci. USA 51 414-421.
19. C.A. Schindler and V.T. Schuhardt (1965) Purification and properties of lysostaphin: a lytic agent for Staphylococcus aureus. Biochim. Biophys. Acta 97 242-250.
20. P.J. Severance, C.A. Kauffman and J.N. Sheagren (1980) Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity. J. Clin. Microbiol. 11 724-727.
21. B.L. Vallee and D.S. Auld (1992) Active zinc binding sites of zinc metalloenzymes. Matrix suppl. 1 5-19.
22. W.A. Zygmunt and P.A. Tavormina (1972) Lysostaphin: model for a specific enzymatic approach to infectious disease. Prog. Drug Res. 16 309-333.